Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility

7 Mar 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to CRISPR and Genetic Engineering
Share to Pluripotent Stem Cells Research

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 30853558
DOI: 10.1016/j.stem.2019.02.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 20 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune CompatibilityPMID 30853558Read ↗

Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical applicationSemantic proximity Read ↗

Generation of hypoimmunogenic universal iPSCs through HLA-type gene knockoutSemantic proximity Read ↗

Generation of hypoimmunogenic universal iPS cells through HLA-type gene knockoutSemantic proximity Read ↗

Current status and future perspectives of HLA-edited induced pluripotent stem cellsSemantic proximity Read ↗

Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editingSemantic proximity Read ↗

Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapySemantic proximity Read ↗

CRISPR-Cas9-mediated disruption of B2M and CIITA genes eliminates HLA class I and II expression in human induced pluripotent stem cells (MUSIi001-A-2)Semantic proximity Read ↗

Advances in CRISPR/Cas gene therapy for inborn errors of immunity.Semantic proximity Read ↗

HLA-Knockout: Enabling Allele-Specific Knockout of HLA Class I Genes for Immunogenic Engineering.Semantic proximity Read ↗

Genome editing HLA alleles for a pilot immunocompatible hESC line in a Chinese hESC bank for cell therapies.Semantic proximity Read ↗

Universal cell donor lines: A review of the current researchSemantic proximity Read ↗

Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer ManagementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.